leucine-rich repeat kinase 2 inhibitors

摘要

the present invention relates to new compounds that inhibit lrrk2 kinase activity, processes for their preparation, compositions containing them and their use in the treatment or prevention of diseases associated with or characterized by lrrk2 kinase activity, for example parkinson's disease, alzheimer's disease and amyotrophic lateral sclerosis (als).